大麻衍生物及其合成类似物对照试验中spin偏倚高发:一项meta-流行病学研究
该meta-流行病学研究在巴西圣保罗联邦大学开展,纳入65篇大麻衍生物及其合成类似物治疗用途的对照试验发表文献。44.6%(29/65)的主要疗效结局有统计学显著效果,70.7%(45/65)的结论对干预持 favorable 态度;在36篇主要结局无统计学显著结果的文献中,44.4%(16/36)的结论仍 favorable 或推荐干预,构成spin偏倚。
要点
- 主要结局无显著结果的试验中,44.4%的结论仍推荐干预,构成spin偏倚。
- spin偏倚表现为选择性报告结局、偏离计划统计分析及未考虑估计不确定性。
- 读者未识别spin偏倚可能导致临床采用无效或疗效不确定的干预。
核心结论
- 在主要结局无统计学显著结果的大麻衍生物及其合成类似物对照试验发表文献中,spin偏倚频率达44.4%。
研究设计与样本
- meta-流行病学研究,在巴西圣保罗联邦大学开展,纳入65篇至少含一个疗效主要结局的对照试验发表文献。
主要发现
- 44.6%(29/65)的发表文献主要结局分析显示统计学显著效果。
- 70.7%(45/65)的结论被认为对干预持 favorable 态度。
- 36篇主要结局无统计学显著结果的文献中,44.4%(16/36)的结论对干预持 favorable 态度或推荐干预。
- 对16篇存在spin偏倚的研究进行定性分析,发现选择性结局报告、偏离计划统计分析及未考虑或报告治疗效应估计的不确定性。
关键数值与推荐
- spin偏倚定义:主要结局无统计学显著结果但结论对干预持 favorable 态度或推荐干预。
临床怎么用
- 阅读大麻衍生物及其合成类似物对照试验文献时,应警惕主要结局无显著结果但结论仍推荐干预的spin偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the frequency and perform a qualitative analysis of spin bias in publications of controlled trials assessing the therapeutic use of cannabis derivatives and their synthetic analogues. STUDY DESIGN AND SETTING: Meta-epidemiologic study carried out at the Universidade Federal de São Paulo, Brazil. RESULTS: A total of 65 publications with at least one efficacy primary outcome were considered. The results analysis for the primary outcome indicated statistically significant effects in 44.6% (29/65) of the publications, and 70.7% (45/65) of the conclusions were considered favorable to the intervention. Among the 36 publications that found statistically nonsignificant results for the primary outcome, 44.4% (16/36) presented conclusions favorable to or recommending the intervention, which represents spin bias according to the definition adopted in this study. Qualitative analysis of the 16 studies with spin bias showed selective outcomes reporting (elevating secondary outcomes that had positive results or reporting only subgroup results), deviations from the planned statistical analysis, and failure to consider or report uncertainty in the estimates of treatment effects. CONCLUSION: The frequency of spin bias among publications of controlled trials with statistically nonsignificant results assessing the therapeutic use of cannabis derivatives and their synthetic analogues reached 44.4%. When not observed by readers, such deviation can lead to misconduct in clinical practice through the adoption of interventions that are not effective or whose effectiveness is uncertain.
引用
- Pereira GC, Prates G, Medina M, et al. High frequency of spin bias in controlled trials of cannabis derivatives and their synthetic analogues: A meta-epidemiologic study. J Clin Epidemiol. 2021. PMID: 34450305. doi:10.1016/j.jclinepi.2021.08.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。